-+ 0.00%
-+ 0.00%
-+ 0.00%

Niagen Bioscience Sees FY2026 Sales $142.365M-$148.836M vs $153.215M Est

Benzinga·03/04/2026 21:06:09
Listen to the news
Niagen Bioscience (NASDAQ:NAGE) sees FY2026 sales of $142.365 million-$148.836 million vs $153.215 million analyst estimate.